WHO ICTRP trial
comparison of topical Luliconazole vs topical Naftifine
CTRI/2025/10/096259 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/10/096259 |
|---|---|
| Public title | comparison of topical Luliconazole vs topical Naftifine |
| Scientific title | Comparison of Topical 2 percent Luliconazole vs Topical 2 percent Naftifine in patients of Tinea Cruris and or Tinea Corporis an Open level Randomized Clinical Trial - NIL |
| Primary sponsor | Rupam Roy |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
| Interventions | Intervention1: Topical Luliconazole: Topical Luliconazole in patients of Tinea Cruris and or Tinea Corporis, Total duration of the study is one and half years Control Intervention1: Topical Naftifine: Topical Naftifine in patients of Tinea… |
| Registration date | Oct 21, 2025 |
| Target size | 130 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: